Insights
Insights From Our Experts
Articles
Booming but Constrained: Digital Therapeutics for Mental Health in APAC
Digital therapeutics (DTx) are a fast-emerging class of therapies that use software to treat disease, both as standalone treatments and for treatment optimization. Applications range from improving patient adherence to supporting physicians in managing patients remotely.…
Need for RWE in Consumer Health and Its Impact in Managing Lifecycle of Consumer Health Products
Healthcare has never been more important to the world than in the past two years and it will remain central during the economic recovery. The pandemic’s impact on medical and healthcare systems has emphasized the value…
New Medicines, New Access, New Frontiers
How psychedelics, cell therapies and other innovations are driving regulatory reform and new patient access Science is improving exponentially. What’s now possible, through new medicines, and entirely new categories of medicine, could only be dreamt of…
KAM Reimagined: Building a Strategic Framework to Empower Key Account Management
Key account management (KAM), as a more innovative approach to pharmaceutical sales and account engagement, promises to deliver long-term, mutually beneficial partnerships between biopharmaceutical manufacturers, healthcare systems and provider practices (AKA target accounts). These partnership structures…
Operational Concerns for Key Enacted and Proposed Changes Under Medicare and Medicaid
EVERSANA’s Mike Kurland, Vice President, Revenue Management & Compliance, delivered a presentation on Operational Concerns for Key Enacted and Proposed Changes Under Medicare and Medicaid at Informa Connect’s Medicaid & Government Pricing Congress. Mike discussed the…
Overcome In-Licensing Barriers to Increase Throughput of Assets
In-licensing is an important growth channel for pharmaceutical companies as they continue to seek more catalysts for growth. In-licensing is used to expand or consolidate a company’s position in a therapy area but can oftentimes be…
Is Your Digital Communication Strategy Up to Par?
In today’s competitive global market, pharmaceutical companies cannot afford to waste time or resources on strategies that do not fit patient needs or generate scripts. Interconnectivity between all stakeholders and a 360° view of everything that…
EVERSANA’s Integrated Operations, Data-Driven Solutions and Digital Expertise Solve Key Challenges in Market Access and Field Deployment
Pharmaceutical manufacturers relying on the standard model for executing market access and field deployment strategies utilize resources inefficiently and redundantly. By integrating actions across operations, manufacturers can right size company resources, ensure affordability and increase speed…
Case Study: Defining the Rare Disease Patient Journey to Support Commercialization of Therapy
Rare diseases are complex, and with limited research available, therapeutic options are often limited. Gene therapy, a growing area of clinical research, is showing great promise in treatment that may be life-altering for patients with many…
Demystifying Data and Analytics – How to Advance Clinical and Business Objectives
The need to develop a strong, comprehensive data-analytics strategy to support pharma and healthcare initiatives cannot be stated strongly enough. Data is unbiased; it can validate hypotheses or provide direction. But the primary goal is to…